The Latest Headlines at American Banking and Market News
Henry Townsing Sells 100,000 Shares of Vita Life Sciences Limited (ASX:VLS) Stock
Vita Life Sciences Limited (ASX:VLS – Get Free Report) insider Henry Townsing sold 100,000 shares of the company’s stock in a transaction on Friday, April 12th. The shares were sold at an average price of A$2.10 ($1.35),... More of this article »
Adrian Haigh Sells 22,222 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) Stock
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of Fennec Pharmaceuticals stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $9.91, for... More of this article »
Daniel L. Johnson Purchases 3,350 Shares of Fastenal (NASDAQ:FAST) Stock
Fastenal (NASDAQ:FAST – Get Free Report) Director Daniel L. Johnson purchased 3,350 shares of the firm’s stock in a transaction dated Wednesday, April 17th. The stock was acquired at an average price of $68.38 per share,... More of this article »
Joseph B. Armes Sells 1,000 Shares of CSW Industrials, Inc. (NASDAQ:CSWI) Stock
CSW Industrials, Inc. (NASDAQ:CSWI – Get Free Report) CEO Joseph B. Armes sold 1,000 shares of the stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $232.69, for a total transaction... More of this article »
Timothy P. Noyes Sells 10,000 Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Stock
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of the business’s stock in a transaction dated Tuesday, April 16th. The stock was sold at an average price of $24.70, for... More of this article »
Scotiabank Lowers Crown Castle (NYSE:CCI) Price Target to $118.00
Crown Castle (NYSE:CCI – Get Free Report) had its price target dropped by stock analysts at Scotiabank from $133.00 to $118.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “sector perform”... More of this article »
Scotiabank Lowers Sage Therapeutics (NASDAQ:SAGE) Price Target to $19.00
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its target price reduced by Scotiabank from $34.00 to $19.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “sector outperform”... More of this article »
Electronic Arts (NASDAQ:EA) Rating Reiterated by Benchmark
Electronic Arts (NASDAQ:EA – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Benchmark in a research note issued to investors on Thursday, Benzinga reports. They currently have... More of this article »
Jefferies Financial Group Increases Bank of New York Mellon (NYSE:BK) Price Target to $68.00
Bank of New York Mellon (NYSE:BK – Get Free Report) had its price objective hoisted by research analysts at Jefferies Financial Group from $67.00 to $68.00 in a research report issued on Thursday, Benzinga reports. The firm... More of this article »
Crown Castle (NYSE:CCI) PT Lowered to $123.00
Crown Castle (NYSE:CCI – Get Free Report) had its price target dropped by research analysts at Jefferies Financial Group from $126.00 to $123.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage... More of this article »
Citigroup Increases ServiceNow (NYSE:NOW) Price Target to $906.00
ServiceNow (NYSE:NOW – Get Free Report) had its target price lifted by research analysts at Citigroup from $896.00 to $906.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “buy”... More of this article »
Jefferies Financial Group Lowers Fortinet (NASDAQ:FTNT) Price Target to $70.00
Fortinet (NASDAQ:FTNT – Get Free Report) had its price objective dropped by Jefferies Financial Group from $75.00 to $70.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm presently... More of this article »
Sage Therapeutics (NASDAQ:SAGE) Stock Rating Reaffirmed by Needham & Company LLC
Sage Therapeutics (NASDAQ:SAGE – Get Free Report)‘s stock had its “hold” rating reiterated by stock analysts at Needham & Company LLC in a report released on Thursday, Benzinga reports. SAGE has been the... More of this article »